SAM #75N98026Q01176

Sole Source Award for Clonal Hematopoiesis Targeted Sequencing Assay (11,000 Samples)

This opportunity involves a sole-source procurement by the National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), for a targeted sequencing assay related to clonal hematopoiesis of indeterminate potential (CHIP). - The contract will be awarded to Vanderbilt University Medical Center (VUMC), BICK Lab, as they are uniquely qualified to perform the required orthogonal assay. - The scope includes performing targeted sequencing on 11,000 samples to replicate and confirm previous genomic data. - The procurement falls under NAICS code 541990 (All Other Professional, Scientific, and Technical Services). - The period of performance is a 12-month base period. - This is a sole-source award; no other vendors or OEMs are specified or solicited. - The main product is a Clonal Hematopoiesis Targeted Sequencing Assay for 11,000 samples. - The estimated contract value is not specified, but based on the scope, it is likely in the mid- to high-six-figure range. - Potential competitors could include other academic medical centers or genomics labs with similar capabilities, though the notice asserts VUMC's unique qualifications.

Description

Clonal hematopoiesis of indeterminate potential (CHIP)-Targeted assay

View original listing